Aquirian Ltd logo

Aquirian Ltd (AQN)

Market Open
ASX ASX
14.54M Market Cap
74.37 P/E Ratio
- Div Yield
180,969 Volume
0 Eps
Want to track AQN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AQN is not paying dividends to its shareholders.
The last earnings report, released on Aug 27, 2025, missed the consensus estimates by -0.03%. On average, the company has fell short of earnings expectations by -0.015%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

Aquirian Ltd (AQN) FAQ

On which exchange is it traded?

Aquirian Ltd is listed on ASX.

What is its stock symbol?

The ticker symbol is AQN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 14.54M.

Has Aquirian Ltd ever had a stock split?

No, there has never been a stock split.

Aquirian Ltd Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Michael F. Mahoney CEO
ASX Exchange
AU0000158537 ISIN
United States Country
53,000 Employees
- Last Dividend
- Last Split
18 May 1992 IPO Date

Overview

Boston Scientific Corporation is a leading innovator in the medical device industry, specializing in the development, manufacture, and marketing of high-quality medical devices for use in various interventional medical specialties globally. Founded in 1979 and based in Marlborough, Massachusetts, the company plays a crucial role in advancing healthcare through its dedication to improving patient outcomes. Boston Scientific operates through two primary segments: MedSurg and Cardiovascular, covering a broad spectrum of healthcare needs, from gastrointestinal and pulmonary conditions to cardiovascular and neurological disorders.

Products and Services

  • Gastrointestinal and Pulmonary Devices: Includes resolution clips, biliary stent systems, stents, and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes. These devices aid in diagnosing and treating various gastrointestinal and pulmonary conditions.
  • Urological Devices: Comprises ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincters, laser systems, fibers, and hydrogel systems. These products are designed to address urological conditions effectively.
  • Neurological and Chronic Pain Management Devices: Offers spinal cord stimulator systems, proprietary programming software, radiofrequency generators, indirect decompression systems, practice optimization tools, and deep brain stimulation systems. These are intended for treating neurological movement disorders and managing chronic pain.
  • Cardiovascular Technologies: Provides cutting-edge technologies for diagnosing and treating coronary artery disease and aortic valve conditions, including devices like the WATCHMAN FLX, a Left Atrial Appendage Closure Device, and various implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. These include cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems.
  • Diagnosis and Treatment of Heart Rate and Rhythm Disorders: Focuses on devices for the diagnosis and treatment of peripheral arterial and venous diseases, and solutions to diagnose, treat, and manage various forms of cancer. This broad category ensures comprehensive care for patients suffering from rate and rhythm disorders of the heart, showcasing Boston Scientific's commitment to cardiac health.

Contact Information

Address: 300 Boston Scientific Way
Phone: 508 683 4000